FAVORITO TAMARA A — SEC Form 4 filings
SEC reporting owner CIK 1288232. 10 Form 4 filings on record with FilingPulse; latest filed 2026-07-21.
Transaction summary — filings shown
Covers all 10 filings on record, filed 2024-03-01 to 2026-07-21. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 1 leg across 1 filing — 3,175 shares, $24,718 total (shares × price as filed).
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 21.
- Largest priced transaction: purchase of 3,175 shares @ $7.79 ($24,718) in ZEVRA THERAPEUTICS, INC., filed 2025-09-16.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| ZEVRA THERAPEUTICS, INC. (ZVRA) | Director | 4 | 1 leg · 3,175 sh · $24,718 | — | 3 |
| ARTELO BIOSCIENCES, INC. (ARTL) | Director | 6 | — | — | 18 |
Form 4 filings — FAVORITO TAMARA A
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-07-21 | 4 | ARTELO BIOSCIENCES, INC. (ARTL) | Grant/award (A): 136 (derivative) @ $0 | EDGAR |
| 2026-06-18 | 4 | ZEVRA THERAPEUTICS, INC. (ZVRA) | Grant/award (A): 30,000 (derivative) @ $0 | EDGAR |
| 2026-02-02 | 4 | ARTELO BIOSCIENCES, INC. (ARTL) | Grant/award (A): 292 (derivative) @ $0 | EDGAR |
| 2025-10-30 | 4 | ARTELO BIOSCIENCES, INC. (ARTL) | Conversion (C) @ $25,000 · Conversion (C): 6,846 (derivative) · Conversion (C): 12,566 (derivative) · Conversion (C) @ $19,793 | EDGAR |
| 2025-09-16 | 4 | ZEVRA THERAPEUTICS, INC. (ZVRA) | Purchase (P): 3,175 @ $7.79 | EDGAR |
| 2025-05-30 | 4 | ZEVRA THERAPEUTICS, INC. (ZVRA) | Grant/award (A): 30,000 (derivative) @ $0 | EDGAR |
| 2025-05-05 | 4 | ARTELO BIOSCIENCES, INC. (ARTL) | Purchase (P) @ $25,000 | EDGAR |
| 2024-12-23 | 4 | ARTELO BIOSCIENCES, INC. (ARTL) | Grant/award (A): 1,750 (derivative) @ $0 | EDGAR |
| 2024-05-15 | 4 | ZEVRA THERAPEUTICS, INC. (ZVRA) | Grant/award (A): 49,200 (derivative) @ $0 | EDGAR |
| 2024-03-01 | 4 | ARTELO BIOSCIENCES, INC. (ARTL) | Disposition to issuer (D): 2,000 (derivative) · Disposition to issuer (D): 667 (derivative) · Disposition to issuer (D): 667 (derivative) · Disposition to issuer (D): 667 (derivative) · Disposition to issuer (D): 1,083 (derivative) · Grant/award (A): 2,000 (derivative) · +4 more | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1288232 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →